During the past decade, Centre d'oncologie et de radiothérapie du Parc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre d'oncologie et de radiothérapie du Parc" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored, "UNICANCER" with 2 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 1 trials sponsored and "Institut Claudius Regaud" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre d'oncologie et de radiothérapie du Parc" #1 collaborator was "Ferring Pharmaceuticals" with 1 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centre d'oncologie et de radiothérapie du Parc" are "Lung Cancer" (2 trials), "Adenocarcinoma of Prostate" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "Anus" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Centre d'oncologie et de radiothérapie du Parc" in a lesser frequency.

Most popular intervention types in "Centre d'oncologie et de radiothérapie du Parc" are "Drug" (5 trials), "Other" (2 trials), "Radiation" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anti-EGFR agent (cetuximab +/- irinotecan or panitumumab)" (1 trials), "CHEMOTHERAPY then HORMONOTHERAPY" (1 trials), "Cisplatin" (1 trials), "Construction of a prognostic score (non-drug intervention types)" (1 trials) and "Degarelix" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre d'oncologie et de radiothérapie du Parc" are 6 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre d'oncologie et de radiothérapie du Parc". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centre d'oncologie et de radiothérapie du Parc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre d'oncologie et de radiothérapie du Parc, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".